The Latest in Psoriatic Arthritis ICYMI

Pregnancy registries are a valuable resource for dermatologists

September 24, 2018

Psoriatic Arthritis

Pregnancy registries are a valuable resource

September 21, 2018

Psoriatic Arthritis

Novel oral agent shows unprecedented efficacy in psoriasis

September 19, 2018

Psoriatic Arthritis

Elevated type 2 diabetes risk seen in PsA patients

September 17, 2018

Psoriatic Arthritis

Psoriatic arthritis activity spikes briefly postpartum

September 12, 2018

Psoriatic Arthritis

Infliximab biosimilar only moderately less expensive in Medicare Part D

September 6, 2018

Psoriatic Arthritis

Sustained minimal disease activity in PsA reduced CV risk factors

August 30, 2018

Psoriatic Arthritis

Medication app boosts psoriasis patients’ short-term adherence

August 30, 2018

Psoriatic Arthritis

Risankizumab proves more effective in psoriasis than ustekinumab

August 28, 2018

Psoriatic Arthritis

Psoriasis registry study provides more data on infliximab’s infection risk

August 16, 2018

Psoriatic Arthritis

AS inflammatory back pain criteria fall short in PsA

August 9, 2018

Psoriatic Arthritis

Psoriasis pipeline is full of biologics

August 2, 2018

Psoriatic Arthritis

FDA announces plan for biosimilar innovation and competition

July 19, 2018

Psoriatic Arthritis

Extended data support ixekizumab for plaque psoriasis

July 18, 2018

Psoriatic Arthritis

Biosimilar switch accepted by most rheumatic disease patients

July 9, 2018

Psoriatic Arthritis